Arca
Skip to content
Tools
Tools

Pyrophosphate

Small molecule that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 1

Approved1

  • Asfotase alfa

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        Asfotase alfaBoxed warningApprovedAstraZeneca PharmaceuticalsProtein or peptideHydrolytic enzymePyrophosphate hydrolytic enzyme4

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 4 in all, from ClinicalTrials.gov.
        Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase AlfaAsfotase alfaPhase 3Active, not recruitingAlexion Pharmaceuticals, Inc.Oct 12, 2023
        Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase AlfaAsfotase alfaPhase 3Active, not recruitingAlexion Pharmaceuticals, Inc.Oct 12, 2023
        Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPPAsfotase alfaPhase 3Active, not recruitingAlexion Pharmaceuticals, Inc.Oct 12, 2023
        A Prospective Sub-Study of the Global Hypophosphatasia RegistryAsfotase alfa—RecruitingAlexion Pharmaceuticals, Inc.Feb 10, 2022

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3545435, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.